Misonix designs, manufactures and markets minimally invasive surgical ultrasonic medical devices. These products include BoneScalpel Surgical System, which is used for surgical procedures involving the cutting and sculpting of bone while sparing soft tissue; SonaStar Surgical Aspirator, which is used to emulsify and remove soft and hard tumors, primarily in the neuro and general surgery fields; and SonicOne Wound Debridement System, which provides tissue debridement and cleansing of wounds and burns for removal of devitalized tissue and fibrin deposits while sparing viable cells. These devices primarily serve the following clinical areas: neurosurgery, wound care and maxillo-facial surgery. The MSON stock yearly return is shown above.
The yearly return on the MSON stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2014 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the MSON annual return calculation with any dividends reinvested as applicable (on ex-dates).
|